| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Clay W Scott | |
| Matthew F Peters | |||
| P433 | issue | 17-18 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | G protein-coupled receptor | Q38173 |
| P304 | page(s) | 704-716 | |
| P577 | publication date | 2010-06-23 | |
| P1433 | published in | Drug Discovery Today | Q3040085 |
| P1476 | title | Label-free whole-cell assays: expanding the scope of GPCR screening | |
| P478 | volume | 15 |
| Q30420969 | A Comparative Study of Impedance versus Optical Label-Free Systems Relative to Labelled Assays in a Predominantly Gi Coupled GPCR (C5aR) Signalling. |
| Q50101527 | A novel microfluidic microelectrode chip for a significantly enhanced monitoring of NPY-receptor activation in live mode. |
| Q28740731 | Agonist-directed desensitization of the β2-adrenergic receptor |
| Q36841982 | Allosteric modulation and functional selectivity of G protein-coupled receptors. |
| Q51513968 | Applying label-free dynamic mass redistribution technology to frame signaling of G protein-coupled receptors noninvasively in living cells. |
| Q51601857 | Are we just learning the scales on the chemokine receptor pianos? |
| Q46911058 | Buserelin alleviates chloride transport defect in human cystic fibrosis nasal epithelial cells |
| Q36463676 | C5a receptor-dependent cell activation by physiological concentrations of desarginated C5a: insights from a novel label-free cellular assay |
| Q45288843 | Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk |
| Q36301873 | Cell-impedance-based label-free technology for the identification of new drugs |
| Q39136383 | Combined optical and electronic sensing of epithelial cells using planar organic transistors |
| Q38926032 | Detection and quantification of allosteric modulation of endogenous m4 muscarinic acetylcholine receptor using impedance-based label-free technology in a neuronal cell line. |
| Q36311216 | Development of a test that measures real-time HER2 signaling function in live breast cancer cell lines and primary cells |
| Q36294093 | Development of ghrelin resistance in a cancer cachexia rat model using human gastric cancer-derived 85As2 cells and the palliative effects of the Kampo medicine rikkunshito on the model |
| Q37263512 | Effects for Sequential Treatment of siAkt and Paclitaxel on Gastric Cancer Cell Lines. |
| Q35529100 | Emergence of Chinese drug discovery research: impact of hit and lead identification |
| Q38192536 | Experimental tools to monitor the dynamics of endothelial barrier function: a survey of in vitro approaches |
| Q37648861 | GPER-mediated proliferation and estradiol production in breast cancer-associated fibroblasts |
| Q24319705 | Galanin pathogenic mutations in temporal lobe epilepsy |
| Q34953430 | Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signalling |
| Q38925674 | Holistic Methods for the Analysis of cNMP Effects |
| Q58551148 | Human 3D Gastrointestinal Microtissue Barrier Function as a Predictor of Drug-Induced Diarrhea |
| Q38240972 | Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line. |
| Q38777517 | Intensity interrogation near cutoff resonance for label-free cellular profiling. |
| Q41773603 | Kinetics of the early events of GPCR signalling |
| Q50569577 | Label-Free Dynamic Mass Redistribution and Bio-Impedance Methods for Drug Discovery. |
| Q42839383 | Label-Free Imaging of Histamine Mediated G Protein-Coupled Receptors Activation in Live Cells |
| Q39013350 | Label-free cell-based dynamic mass redistribution assays |
| Q90261793 | Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1 |
| Q92850046 | Label-free dynamic mass redistribution analysis of endogenous adrenergic receptor signaling in primary preadipocytes and differentiated adipocytes |
| Q28709650 | Label-free integrative pharmacology on-target of opioid ligands at the opioid receptor family |
| Q28730612 | Label-free phenotypic profiling identified D-luciferin as a GPR35 agonist |
| Q38014954 | Ligand functional selectivity and quantitative pharmacology at G protein-coupled receptors |
| Q30656460 | Machine learning plus optical flow: a simple and sensitive method to detect cardioactive drugs |
| Q33636151 | Novel delta opioid receptor agonists with oxazatricyclodecane structure |
| Q62657706 | Optimization of a Planar All-Polymer Transistor for Characterization of Barrier Tissue |
| Q31154360 | Potential strategies for increasing drug-discovery productivity. |
| Q47685791 | The development of label-free cellular assays for drug discovery |
| Q27007472 | Tools for GPCR drug discovery |
| Q35662230 | Tricyclic Antidepressant Amitriptyline-induced Glial Cell Line-derived Neurotrophic Factor Production Involves Pertussis Toxin-sensitive Gαi/o Activation in Astroglial Cells |
| Q46013288 | Troubleshooting and deconvoluting label-free cell phenotypic assays in drug discovery. |
| Q51377000 | Using Biosensors to Study Free Fatty Acid Receptor Pharmacology and Function. |
| Q37999094 | Using label-free screening technology to improve efficiency in drug discovery |
Search more.